Researchers at Imperial are partnering with Bayer Pharmaceuticals to explore how artificial intelligence (AI) can accelerate the discovery of new drugs for heart conditions. An estimated seven million people are living with heart and circulatory disease in the UK alone, with cardiovascular diseases responsible for one in four deaths. Identifying and treating patients at an […]
AI to help find new heart drugs
